BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khan S, Soni S, Veerapu NS. HCV Replicon Systems: Workhorses of Drug Discovery and Resistance. Front Cell Infect Microbiol 2020;10:325. [PMID: 32714881 DOI: 10.3389/fcimb.2020.00325] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang H, Zhao X, Xun M, Ma C, Wang H. Reverse Genetic Approaches for the Generation of Full Length and Subgenomic Replicon of EV71 Virus. Front Microbiol 2021;12:665879. [PMID: 34093481 DOI: 10.3389/fmicb.2021.665879] [Reference Citation Analysis]
2 Gu W, Ueda Y, Dansako H, Satoh S, Kato N. Antiviral mechanism of preclinical antimalarial compounds possessing multiple antiviral activities. FASEB Bioadv 2021;3:356-73. [PMID: 33977235 DOI: 10.1096/fba.2020-00107] [Reference Citation Analysis]
3 Zhu S, Liu B, Xu Y, Zhang L, Xia Z, Liu J, Zhou X, Fu Y, Allain J, Li C, Li T. Two New Purification Methods of Hepatitis C Virus Particles from Serum-Free Culture System. Hepat Mon 2021;21. [DOI: 10.5812/hepatmon.115727] [Reference Citation Analysis]
4 Guinan M, Huang N, Smith M, Miller GJ. Design, chemical synthesis and antiviral evaluation of 2'-deoxy-2'-fluoro-2'-C-methyl-4'-thionucleosides. Bioorg Med Chem Lett 2022;:128605. [PMID: 35123007 DOI: 10.1016/j.bmcl.2022.128605] [Reference Citation Analysis]
5 Soni S, Singh D, Aggarwal R, Veerapu NS. Enhanced fitness of hepatitis C virus increases resistance to direct-acting antivirals. J Gen Virol 2022;103. [PMID: 35133954 DOI: 10.1099/jgv.0.001699] [Reference Citation Analysis]